News | Gastrointestinal system diseases

News

Type 2 diabetes drug may be associated with inflammatory bowel disease

Early results from a trial investigating the link between antidiabetic drugs and autoimmune diseases may have found an association, researchers have revealed…

Published: 23 April 2018

News

More research needed to investigate role of vitamin D in IBS treatment

A group of researchers has concluded that, while the literature indicates a potential role, further studies are needed before vitamin D can be considered a therapeutic option for people living with irritable bowel syndrome.…

Published: 13 March 2018

News

Research identifies potential target for treating inflammatory skin diseases

Targeting Ripk1 could be an effective treatment for skin conditions such as eczema and psoriasis, a study finds.…

Published: 22 September 2017

News

Study finds no support for link between Alzheimer’s disease and PPIs

Researchers conclude that there is no clinically meaningful association between PPI use and risk of Alzheimer’s disease.…

Published: 11 September 2017

News

Antibiotics in late pregnancy linked to inflammatory bowel disease

Researchers found that exposure to the antibiotic cefoperazone resulted in gut microbial imbalances in the mother that were transmitted to their offspring.…

Published: 4 August 2017

Opinion

Living in a microbial world

I contain multitudes: the microbes within us and a grander view of life, by Ed Yong.…

Published: 12 July 2017

Opinion

How gut bacteria affect our overall health and wellbeing

The clever guts diet: how to revolutionise your body from the inside out, by Michael Mosley…

Published: 12 July 2017

News

Scrap prescription charges for all long-term conditions, charities urge

The cost of prescriptions is putting many patients off collecting the medicines they need, a new report has found.…

Published: 4 July 2017

News

Ustekinumab approved by NICE for treatment of Crohn’s disease

The National Institute of Health and Care Excellence (NICE) has approved ustekinumab (Stelara; Janssen) as a treatment for patients with moderate to severe Crohn’s disease who have had little or no response, or an intolerance, to existing therapies.…

Published: 26 June 2017

News

Aspirin and PPIs should be co-prescribed in older patients because of bleeding risk, say researchers

Patients aged over 75 years who take aspirin-based antiplatelet therapy should be co-prescribed proton-pump inhibitors because of an under-recognised risk of disabling gastrointestinal bleeding, reports a Lancet study.…

Published: 14 June 2017